Fecal Phagocyte-specific S100A12 for diagnosing necrotizing enterocolitis

Journal of Pediatrics

Volumn 161, Issue 6, 2012, Pages 1059-1064

  Däbritz, Jan ^a,b   Jenke, Andreas ^c   Wirth, Stefan ^c   Foell, Dirk ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c HELIOS KLINIKUM WUPPERTAL   (Germany)

Author keywords

C reactive protein; CRP; ELISA; Enzyme linked immunosorbent assay; GA; Gestational age; IL 6; Interleukin 6; NEC; Necrotizing enterocolitis; Receiver operating characteristic; ROC; Very low birth weight; VLBW

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN; S100 A12; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL MONITORING; BIRTH WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MECONIUM; NECROTIZING ENTEROCOLITIS; NEWBORN; PHAGOCYTE; PREDICTION; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; COHORT STUDIES; ENTEROCOLITIS, NECROTIZING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MECONIUM; PROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84869507961     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2012.06.003     Document Type: Article

References (22)

1. M. Ayşe Selimoǧlu, I. Temel, C. Yildirim, F. Ozyalin, M. Aktaş, and H. Karabiber The role of fecal calprotectin and lactoferrin in the diagnosis of necrotizing enterocolitis Pediatr Crit Care Med 2011 Nov 10 [Epub ahead of print]
2. S. Josefsson, S.K. Bunn, and M. Domellöf Fecal calprotectin in very low birth weight infants J Pediatr Gastroenterol Nutr 44 2007 407 413
3. P.W. Lin, and B.J. Stoll Necrotising enterocolitis Lancet 368 2006 1271 1283
4. L. Berman, and R.L. Moss Necrotizing enterocolitis: an update Semin Fetal Neonatal Med 16 2011 145 150
5. G. Thuijls, J.P. Derikx, K. van Wijck, L.J. Zimmermann, P.L. Degraeuwe, and T.L. Mulder Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis Ann Surg 251 2010 1174 1180
6. D. Foell, H. Wittkowski, and J. Roth Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage Gut 58 2009 859 868
7. T. Vogl, K. Tenbrock, S. Ludwig, N. Leukert, C. Ehrhardt, and M.A. van Zoelen Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock Nat Med 13 2007 1042 1049
8. D. Foell, F. Ichida, T. Vogl, X. Yu, R. Chen, and T. Miyawaki S100A12 (EN-RAGE) in monitoring Kawasaki disease Lancet 361 2003 1270 1272
9. H. Wittkowski, A. Sturrock, M.A. van Zoelen, D. Viemann, T. van der Poll, and J.R. Hoidal Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome Crit Care Med 35 2007 1369 1375
10. N.S. de Jong, S.T. Leach, and A.S. Day Fecal S100A12: a novel noninvasive marker in children with Crohn's disease Inflamm Bowel Dis 12 2006 566 572
11. D. Foell, H. Wittkowski, Z. Ren, J. Turton, G. Pang, and J. Daebritz Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease J Pathol 216 2008 183 192
12. T. Kaiser, J. Langhorst, H. Wittkowski, K. Becker, A.W. Friedrich, and A. Rueffer Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome Gut 56 2007 1706 1713
13. M.C. Walsh, and R.M. Kliegman Necrotizing enterocolitis: treatment based on staging criteria Pediatr Clin North Am 33 1986 179 201
14. D. Foell, T. Kucharzik, M. Kraft, T. Vogl, C. Sorg, and W. Domschke Neutrophil- derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease Gut 52 2003 847 853
15. D. Carroll, A. Corfield, R. Spicer, and P. Cairns Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis Lancet 361 2003 310 311
16. Q. Yang, P.B. Smith, R.N. Goldberg, and C.M. Cotten Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life Neonatology 94 2008 267 271
17. A.C. Nissen, C.E. van Gils, P.P. Menheere, A.M. Van den Neucker, M.A. van der Hoeven, and P.P. Forget Fecal calprotectin in healthy term and preterm infants J Pediatr Gastroenterol Nutr 38 2004 107 108
18. C. Rougé, M.J. Butel, H. Piloquet, L. Ferraris, A. Legrand, and M. Vodovar Fecal calprotectin excretion in preterm infants during the neonatal period PLoS ONE 5 2010 e11083
19. F. Campeotto, M. Baldassarre, M.J. Butel, V. Viallon, F. Nganzali, and P. Soulaines Fecal calprotectin: cutoff values for identifying intestinal distress in preterm infants J Pediatr Gastroenterol Nutr 48 2009 507 510
20. J.A. Morgan, L. Young, and W. McGuire Pathogenesis and prevention of necrotizing enterocolitis Curr Opin Infect Dis 24 2011 183 189
21. C.N. Emami, M. Petrosyan, S. Giuliani, M. Williams, C. Hunter, and N.V. Prasadarao Role of the host defense system and intestinal microbial flora in the pathogenesis of necrotizing enterocolitis Surg Infect 10 2009 407 417
22. N. Laforgia, M.E. Baldassarre, G. Pontrelli, F. Indrio, M.A. Altomare, and G. Di Bitonto Calprotectin levels in meconium Acta Paediatr 92 2003 463 466